Skip to main content
. 2009 Dec 18;2(6):431–435. doi: 10.1111/j.1752-8062.2009.00168.x

Table 1.

Univariate association of dichotomous variables with the presence of valvular ossification.

Variable N Bone present % (#) Bone absent % (#) OR 95% CI p
Warfarin use 195 16.7 (5) 3.6 (6) 5.30 1.59, 17.72 0.004
African American versus Caucasian race 192 13.3 (4) 2.5 (4) 6.08 1.56, 23.7 0.006
Left ventricular hypertrophy 165 84.6 (22) 95.0 (132) 0.29 0.083, 1.01 0.052
Diabetes mellitus 195 16.7 (5) 33.3 (55) 0.40 0.15, 1.07 0.069
Female sex 195 26.7 (8) 44.2 (73) 0.46 0.20, 1.07 0.072
Mitral regurgitation 166 59.3 (16) 74.8 (104) 0.49 0.21, 1.14 0.098
Hypertension 195 40.0 (12) 53.9 (89) 0.57 0.26,1.24 0.160
Current cigarette smoking 194 6.7 (2) 16.5 (27) 0.36 0.00, 1.46 0.167
Statin use 195 3.3 (1) 11.5 (19) 0.26 0.00, 1.62 0.174
Coronary artery disease 195 73.3 (22) 61.2 (101) 1.74 0.74, 4.07 0.206
Carotid artery disease 195 6.7 (2) 15.2 (25) 0.4 0.00, 1.62 0.216
Glucocorticoid use 194 3.3 (1) 7.3 (12) 0.44 0.00, 2.75 0.422
Estrogen replacement therapy 81 0 (0) 6.17 (5) 0 0.00, 7.31 0.445
Bicuspid valve (versus tricuspid) 195 26.7 (8) 20.9 (34) 1.40 0.58, 3.32 0.479
Peripheral artery disease 195 10.0 (3) 7.3 (12) 1.42 0.40, 5.03 0.606
Bisphosphonate use 194 0 (0) 0.61 (1) 0 0 0.669
Aortic valve insufficiency 157 66.7 (16) 66.2 (88) 1.02 0.41, 2.51 0.962